Protein Oxidation in Aging: Does It Play a Role in Aging Progression?

Antioxidants and Redox Signaling

Volumn 23, Issue 3, 2015, Pages 239-255

  Reeg, Sandra ^a   Grune, Tilman ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOFUSCIN; METAL ION; OXIDIZING AGENT; PROTEASOME; PROTEIN AGGREGATE; REACTIVE OXYGEN METABOLITE; PROTEIN;

AGE RELATED MACULAR DEGENERATION; AGING; ALZHEIMER DISEASE; APOPTOSIS; ATHEROSCLEROSIS; BIOACCUMULATION; CELL AGING; DEGENERATIVE DISEASE; HUMAN; HUNTINGTON CHOREA; LYSOSOME; MACROMOLECULE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN MODIFICATION; PROTEIN OXIDATION; REVIEW; SENESCENCE; ANIMAL; CHEMISTRY; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS;

AGING; ANIMALS; APOPTOSIS; HUMANS; LIPOFUSCIN; LYSOSOMES; NEURODEGENERATIVE DISEASES; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN AGGREGATES; PROTEINS;

EID: 84974727253     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2014.6062     Document Type: Review

References (164)

1. Abeliovich A, Schmitz Y, Farinas I, Choi-Lundberg D, Ho WH, Castillo PE, Shinsky N, Verdugo JM, Armanini M, Ryan A, Hynes M, Phillips H, Sulzer D, Rosenthal A. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25: 239-252, 2000.
2. Aeschbach R, Amado R, Neukom H. Formation of dityrosine cross-links in proteins by oxidation of tyrosine residues. Biochim Biophys Acta 439: 292-301, 1976.
3. Aksenov MY, Aksenova MV, Butterfield DA, Geddes JW, Markesbery WR. Protein oxidation in the brain in Alzheimer's disease. Neuroscience 103: 373-383, 2001.
4. Alberti S, Demand J, Esser C, Emmerich N, Schild H, Hohfeld J. Ubiquitylation of BAG-1 suggests a novel regulatory mechanism during the sorting of chaperone substrates to the proteasome. J Biol Chem 277: 45920-45927, 2002.
5. Antunes F, Cadenas E, Brunk UT. Apoptosis induced by exposure to a low steady-state concentration of H2O2 is a consequence of lysosomal rupture. Biochem J 356: 549-555, 2001.
6. Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, Kirkland JL, van Deursen JM. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479: 232-236, 2011.
7. Barry-Lane PA, Patterson C, van der Merwe M, Hu Z, Holland SM, Yeh ET, Runge MS. p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest 108: 1513-1522, 2001.
8. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45: 115-134, 2000.
9. Benavides SH, Monserrat AJ, Farina S, Porta EA. Sequential histochemical studies of neuronal lipofuscin in human cerebral cortex from the first to the ninth decade of life. Arch Gerontol Geriatr 34: 219-231, 2002.
10. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3: 1301-1306, 2000.
11. Bindoli A, Fukuto JM, Forman HJ. Thiol chemistry in peroxidase catalysis and redox signaling. Antioxid Redox Signal 10: 1549-1564, 2008.
12. Boya P and Kroemer G. Lysosomal membrane permeabilization in cell death. Oncogene 27: 6434-6451, 2008.
13. Browne SE and Beal MF. Oxidative damage in Huntington's disease pathogenesis. Antioxid Redox Signal 8: 2061-2073, 2006.
14. Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muqit MM, Bird ED, Beal MF. Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann Neurol 41: 646-653, 1997.
15. Brunk UT and Terman A. Lipofuscin: mechanisms of agerelated accumulation and influence on cell function. Free Radic Biol Med 33: 611-619, 2002.
16. Brunk UT and Terman A. The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur J Biochem 269: 1996-2002, 2002.
17. Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33: 95-130, 2000.
18. Bulteau AL, Petropoulos I, Friguet B. Age-related alterations of proteasome structure and function in aging epidermis. Exp Gerontol 35: 767-777, 2000.
19. Bulteau AL, Szweda LI, Friguet B. Age-dependent declines in proteasome activity in the heart. Arch Biochem Biophys 397: 298-304, 2002.
20. Campisi J and d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8: 729-740, 2007.
21. Carrard G, Dieu M, Raes M, Toussaint O, Friguet B. Impact of ageing on proteasome structure and function in human lymphocytes. Int J Biochem Cell Biol 35: 728-739, 2003.
22. Castro JP, Ott C, Jung T, Grune T, Almeida H. Carbonylation of the cytoskeletal protein actin leads to aggregate formation. Free Radic Biol Med 53: 916-925, 2012.
23. Chen Q and Ames BN. Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. Proc Natl Acad Sci USA 91: 4130-4134, 1994.
24. Collet JF and Messens J. Structure, function, mechanism of thioredoxin proteins. Antioxid Redox Signal 13: 1205-1216, 2010.
25. Conconi M, Petropoulos I, Emod I, Turlin E, Biville F, Friguet B. Protection from oxidative inactivation of the 20S proteasome by heat-shock protein 90. Biochem J 333 (Pt 2): 407-415, 1998.
26. Conconi M, Szweda LI, Levine RL, Stadtman ER, Friguet B. Age-related decline of rat liver multicatalytic proteinase activity and protection from oxidative inactivation by heat-shock protein 90. Arch Biochem Biophys 331: 232-240, 1996.
27. Consortium CeS. Genome sequence of the nematode C. elegans: a platform for investigating biology. Science 282: 2012-2018, 1998.
28. Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, Sakaguchi H, Kamei M, Hasan A, Yan L, Rayborn ME, Salomon RG, Hollyfield JG. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA 99: 14682-14687, 2002.
29. Cuervo AM and Dice JF. A receptor for the selective uptake and degradation of proteins by lysosomes. Science 273: 501-503, 1996.
30. Cuervo AM and Dice JF. Age-related decline in chaperone-mediated autophagy. J Biol Chem 275: 31505-31513, 2000.
31. Cuervo AM and Dice JF. When lysosomes get old. Exp Gerontol 35: 119-131, 2000.
32. Cuervo AM and Wong E. Chaperone-mediated autophagy: roles in disease and aging. Cell Res 24: 92-104, 2014.
33. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 329: 23-38, 2003.
34. Davies KJ. Degradation of oxidized proteins by the 20S proteasome. Biochimie 83: 301-310, 2001.
35. Davies MJ. Protein and peptide alkoxyl radicals can give rise to C-terminal decarboxylation and backbone cleavage. Arch Biochem Biophys 336: 163-172, 1996.
36. Davies MJ. The oxidative environment and protein damage. Biochim Biophys Acta 1703: 93-109, 2005.
37. Double KL, Dedov VN, Fedorow H, Kettle E, Halliday GM, Garner B, Brunk UT. The comparative biology of neuromelanin and lipofuscin in the human brain. Cell Mol Life Sci 65: 1669-1682, 2008.
38. Drazic A and Winter J. The physiological role of reversible methionine oxidation. Biochim Biophys Acta 1844: 1367-1382, 2014.
39. Erickson JR, Joiner ML, Guan X, Kutschke W, Yang J, Oddis CV, Bartlett RK, Lowe JS, O'Donnell SE, Aykin-Burns N, Zimmerman MC, Zimmerman K, Ham AJ, Weiss RM, Spitz DR, Shea MA, Colbran RJ, Mohler PJ,erson ME. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 133: 462-474, 2008.
40. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol 47: C7-C12, 2006.
41. Ferrington DA, Husom AD, Thompson LV. Altered proteasome structure, function, oxidation in aged muscle. FASEB J 19: 644-646, 2005.
42. Floyd RA and Carney JM. Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann Neurol 32 Suppl: S22-S27, 1992.
43. Forman HJ, Maiorino M, Ursini F. Signaling functions of reactive oxygen species. Biochemistry 49: 835-842, 2010.
44. Fortun J, Dunn WA, Jr., Joy S, Li J, Notterpek L. Emerging role for autophagy in the removal of aggresomes in Schwann cells. J Neurosci 23: 10672-10680, 2003.
45. Friguet B and Szweda LI. Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal crosslinked protein. FEBS Lett 405: 21-25, 1997.
46. Fu S, Davies MJ, Stocker R, Dean RT. Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. Biochem J 333 (Pt 3): 519-525, 1998.
47. Garigan D, Hsu AL, Fraser AG, Kamath RS, Ahringer J, Kenyon C. Genetic analysis of tissue aging in Caenorhabditis elegans: a role for heat-shock factor and bacterial proliferation. Genetics 161: 1101-1112, 2002.
48. Gemma C, Vila J, Bachstetter A, Bickford PC. Oxidative stress and the aging brain: from theory to prevention. In: Brain Aging: Models, Methods, Mechanisms, edited by Riddle DR. Boca Raton, FL: CRC Press, 2007, pp. 353-374.
49. Gems D. Ageing and oxidants in the nematode Caenorhabditis elegans. SEB Exp Biol Ser 62: 31-56, 2009.
50. Gerstbrein B, Stamatas G, Kollias N, Driscoll M. In vivo spectrofluorimetry reveals endogenous biomarkers that report healthspan and dietary restriction in Caenorhabditis elegans. Aging Cell 4: 127-137, 2005.
51. Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VM. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 290: 985-989, 2000.
52. Giulivi C, Pacifici RE, Davies KJ. Exposure of hydrophobic moieties promotes the selective degradation of hydrogen peroxide-modified hemoglobin by the multicatalytic proteinase complex, proteasome. Arch Biochem Biophys 311: 329-341, 1994.
53. Graham A, Hogg N, Kalyanaraman B, O'Leary V, Darley-Usmar V, Moncada S. Peroxynitrite modification of low-density lipoprotein leads to recognition by the macrophage scavenger receptor. FEBS Lett 330: 181-185, 1993.
54. Grune T, Botzen D, Engels M, Voss P, Kaiser B, Jung T, Grimm S, Ermak G, Davies KJ. Tau protein degradation is catalyzed by the ATP/ubiquitin-independent 20S proteasome under normal cell conditions. Arch Biochem Biophys 500: 181-188, 2010.
55. Grune T, Catalgol B, Licht A, Ermak G, Pickering AM, Ngo JK, Davies KJ. HSP70 mediates dissociation and reassociation of the 26S proteasome during adaptation to oxidative stress. Free Radic Biol Med 51: 1355-1364, 2011.
56. Grune T, Reinheckel T, Davies KJ. Degradation of oxidized proteins in mammalian cells. FASEB J 11: 526-534, 1997.
57. Grune T, Reinheckel T, Joshi M, Davies KJ. Proteolysis in cultured liver epithelial cells during oxidative stress. Role of the multicatalytic proteinase complex, proteasome. J Biol Chem 270: 2344-2351, 1995.
58. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 11: 298-300, 1956.
59. Hayflick L and Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 25: 585-621, 1961.
60. Hazell LJ and Stocker R. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem J 290 (Pt 1): 165-172, 1993.
61. Hensley K, Hall N, Subramaniam R, Cole P, Harris M, Aksenov M, Aksenova M, Gabbita SP, Wu JF, Carney JM, et al. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J Neurochem 65: 2146-2156, 1995.
62. Herce-Pagliai C, Kotecha S, Shuker DE. Analytical methods for 3-nitrotyrosine as a marker of exposure to reactive nitrogen species: a review. Nitric Oxide 2: 324-336, 1998.
63. Hipkiss AR. Accumulation of altered proteins and ageing: causes and effects. Exp Gerontol 41: 464-473, 2006.
64. Hodara R, Norris EH, Giasson BI, Mishizen-Eberz AJ, Lynch DR, Lee VM, Ischiropoulos H. Functional consequences of alpha-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation. J Biol Chem 279: 47746-47753, 2004.
65. Höhn A and Grune T. Lipofuscin: formation, effects and role of macroautophagy. Redox Biol 1: 140-144, 2013.
66. Höhn A, Jung T, Grimm S, Catalgol B, Weber D, Grune T. Lipofuscin inhibits the proteasome by binding to surface motifs. Free Radic Biol Med 50: 585-591, 2011.
67. Höhn A, Jung T, Grimm S, Grune T. Lipofuscinbound iron is a major intracellular source of oxidants: role in senescent cells. Free Radic Biol Med 48: 1100-1108, 2010.
68. Höhn A, Konig J, Grune T. Protein oxidation in aging and the removal of oxidized proteins. J Proteomics 92: 132-159, 2013.
69. Höhn A, Sittig A, Jung T, Grimm S, Grune T. Lipofuscin is formed independently of macroautophagy and lysosomal activity in stress-induced prematurely senescent human fibroblasts. Free Radic Biol Med 53: 1760-1769, 2012.
70. Hornsby PJ. Cellular senescence and tissue aging in vivo. J Gerontol A Biol Sci Med Sci 57: B251-B256, 2002.
71. Hoshi T and Heinemann S. Regulation of cell function by methionine oxidation and reduction. J Physiol 531: 1-11, 2001.
72. Hosokawa H, Ishii N, Ishida H, Ichimori K, Nakazawa H, Suzuki K. Rapid accumulation of fluorescent material with aging in an oxygen-sensitive mutant mev-1 of Caenorhabditis elegans. Mech Ageing Dev 74: 161-170, 1994.
73. Howe CJ, Lahair MM, McCubrey JA, Franklin RA. Redox regulation of the calcium/calmodulin-dependent protein kinases. J Biol Chem 279: 44573-44581, 2004.
74. Huang Y and Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell 148: 1204-1222, 2012.
75. Irvine GB, El-Agnaf OM, Shankar GM, Walsh DM. Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases. Mol Med 14: 451-464, 2008.
76. Jahreiss L, Menzies FM, Rubinsztein DC. The itinerary of autophagosomes: from peripheral formation to kiss-and-run fusion with lysosomes. Traffic 9: 574-587, 2008.
77. Jeyapalan JC, Ferreira M, Sedivy JM, Herbig U. Accumulation of senescent cells in mitotic tissue of aging primates. Mech Ageing Dev 128: 36-44, 2007.
78. Jiang D, Li X, Williams R, Patel S, Men L, Wang Y, Zhou F. Ternary complexes of iron, amyloid-beta, nitrilotriacetic acid: binding affinities, redox properties, relevance to iron-induced oxidative stress in Alzheimer's disease. Biochemistry 48: 7939-7947, 2009.
79. Johnston JA, Ward CL, Kopito RR. Aggresomes: a cellular response to misfolded proteins. J Cell Biol 143: 1883-1898, 1998.
80. Jolly RD, Douglas BV, Davey PM, Roiri JE. Lipofuscin in bovine muscle and brain: a model for studying age pigment. Gerontology 41 Suppl 2: 283-295, 1995.
81. Jung T, Catalgol B, Grune T. The proteasomal system. Mol Aspects Med 30: 191-296, 2009.
82. Jung T and Grune T. The proteasome and its role in the degradation of oxidized proteins. IUBMB Life 60: 743-752, 2008.
83. Jung T and Grune T. The proteasome and the degradation of oxidized proteins: Part I-structure of proteasomes. Redox Biol 1: 178-182, 2013.
84. Jung T, Hohn A, Catalgol B, Grune T. Age-related differences in oxidative protein-damage in young and senescent fibroblasts. Arch Biochem Biophys 483: 127-135, 2009.
85. Jung T, Hohn A, Grune T. Lipofuscin: detection and quantification by microscopic techniques. Methods Mol Biol 594: 173-193, 2010.
86. Kamath RS, Fraser AG, Dong Y, Poulin G, Durbin R, Gotta M, Kanapin A, Le Bot N, Moreno S, Sohrmann M, Welchman DP, Zipperlen P, Ahringer J. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 421: 231-237, 2003.
87. Kastle M and Grune T. Proteins bearing oxidationinduced carbonyl groups are not preferentially ubiquitinated. Biochimie 93: 1076-1079, 2011.
88. Keller JN, Huang FF, Markesbery WR. Decreased levels of proteasome activity and proteasome expression in aging spinal cord. Neuroscience 98: 149-156, 2000.
89. Kiffin R, Christian C, Knecht E, Cuervo AM. Activation of chaperone-mediated autophagy during oxidative stress. Mol Biol Cell 15: 4829-4840, 2004.
90. Kirk EA, Dinauer MC, Rosen H, Chait A, Heinecke JW, LeBoeuf RC. Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice. Arterioscler Thromb Vasc Biol 20: 1529-1535, 2000.
91. Kolarova M, Garcia-Sierra F, Bartos A, Ricny J, Ripova D. Structure and pathology of tau protein in Alzheimer disease. Int J Alzheimers Dis 2012: 731526, 2012.
92. Kopito RR. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 10: 524-530, 2000.
93. Kriegenburg F, Ellgaard L, Hartmann-Petersen R. Molecular chaperones in targeting misfolded proteins for ubiquitin-dependent degradation. FEBS J 279: 532-542, 2012.
94. Lamark T and Johansen T. Aggrephagy: selective disposal of protein aggregates by macroautophagy. Int J Cell Biol 2012: 736905, 2012.
95. Lasch P, Petras T, Ullrich O, Backmann J, Naumann D, Grune T. Hydrogen peroxide-induced structural alterations of RNAse A. J Biol Chem 276: 9492-9502, 2001.
96. Lecker SH, Goldberg AL, Mitch WE. Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J Am Soc Nephrol 17: 1807-1819, 2006.
97. Lee CK, Klopp RG, Weindruch R, Prolla TA. Gene expression profile of aging and its retardation by caloric restriction. Science 285: 1390-1393, 1999.
98. Leeuwenburgh C, HardyMM, Hazen SL, Wagner P, Oh-ishi S, Steinbrecher UP, Heinecke JW. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J BiolChem272: 1433-1436, 1997.
99. Leeuwenburgh C, Rasmussen JE, Hsu FF, Mueller DM, Pennathur S, Heinecke JW. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J Biol Chem 272: 3520-3526, 1997.
100. Levine RL, Moskovitz J, Stadtman ER. Oxidation of methionine in proteins: roles in antioxidant defense and cellular regulation. IUBMB Life 50: 301-307, 2000.
101. Liochev SI. Reactive oxygen species and the free radical theory of aging. Free Radic Biol Med 60: 1-4, 2013.
102. Liu R, Liu IY, Bi X, Thompson RF, Doctrow SR, Malfroy B, Baudry M. Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics. Proc Natl Acad Sci USA 100: 8526-8531, 2003.
103. Liu W, Yin Y, Zhou Z, He M, Dai Y. OxLDL-induced IL-1 beta secretion promoting foam cells formation was mainly via CD36 mediated ROS production leading to NLRP3 inflammasome activation. Inflamm Res 63: 33-43, 2014.
104. Longo VD, Shadel GS, Kaeberlein M, Kennedy B. Replicative and chronological aging in Saccharomyces cerevisiae. Cell Metab 16: 18-31, 2012.
105. Lowther WT, Brot N, Weissbach H, Honek JF, Matthews BW. Thiol-disulfide exchange is involved in the catalytic mechanism of peptide methionine sulfoxide reductase. Proc Natl Acad Sci USA 97: 6463-6468, 2000.
106. Luxford C, Dean RT, Davies MJ. Induction of DNA damage by oxidised amino acids and proteins. Biogerontology 3: 95-102, 2002.
107. Mandelkow EM and Mandelkow E. Tau protein and Alzheimer's disease. Neurobiol Aging 15 Suppl 2: S85-S86, 1994.
108. Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA. The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J Biol Chem 277: 1641-1644, 2002.
109. Mariani E, Polidori MC, Cherubini A, Mecocci P. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr B Analyt Technol Biomed Life Sci 827: 65-75, 2005.
110. Martinez A, Portero-Otin M, Pamplona R, Ferrer I. Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates. Brain Pathol 20: 281-297, 2010.
111. Mata NL, Tzekov RT, Liu X, Weng J, Birch DG, Travis GH. Delayed dark-adaptation and lipofuscin accumulation in abcr mice: implications for involvement of ABCR in age-related macular degeneration. Invest Ophthalmol Vis Sci 42: 1685-1690, 2001.
112. Mazzulli JR, Mishizen AJ, Giasson BI, Lynch DR, Thomas SA, Nakashima A, Nagatsu T, Ota A, Ischiropoulos H. Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates. J Neurosci 26: 10068-10078, 2006.
113. McMurray HF, Parthasarathy S, Steinberg D. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J Clin Invest 92: 1004-1008, 1993.
114. Merker K, Sitte N, Grune T. Hydrogen peroxidemediated protein oxidation in young and old human MRC-5 fibroblasts. Arch Biochem Biophys 375: 50-54, 2000.
115. Mijaljica D, Prescott M, Devenish RJ. Microautophagy in mammalian cells: revisiting a 40-year-old conundrum. Autophagy 7: 673-682, 2011.
116. Mori M, Itabe H, Higashi Y, Fujimoto Y, Shiomi M, Yoshizumi M, Ouchi Y, Takano T. Foam cell formation containing lipid droplets enriched with free cholesterol by hyperlipidemic serum. J Lipid Res 42: 1771-1781, 2001.
117. Murata S, Minami Y, Minami M, Chiba T, Tanaka K. CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein. EMBO Rep 2: 1133-1138, 2001.
118. Nakano M and Gotoh S. Accumulation of cardiac lipofuscin depends on metabolic rate of mammals. J Gerontol 47: B126-B129, 1992.
119. Naujokat C and Hoffmann S. Role and function of the 26S proteasome in proliferation and apoptosis. Lab Invest 82: 965-980, 2002.
120. Navab M, Imes SS, Hama SY, Hough GP, Ross LA, Bork RW, Valente AJ, Berliner JA, Drinkwater DC, Laks H, et al. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest 88: 2039-2046, 1991.
121. Neta P, Huie RE, Ross AB. Rate constants for reactions of peroxyl radicals in fluid solutions. J Phys Chem Ref Data 19: 413, 1990.
122. Neuzil J, Gebicki JM, Stocker R. Radical-induced chain oxidation of proteins and its inhibition by chain-breaking antioxidants. Biochem J 293 (Pt 3): 601-606, 1993.
123. Norris EH, Giasson BI, Hodara R, Xu S, Trojanowski JQ, Ischiropoulos H, Lee VM. Reversible inhibition of alphasynuclein fibrillization by dopaminochrome-mediated conformational alterations. J Biol Chem 280: 21212-21219, 2005.
124. Oliver CN, Ahn BW, Moerman EJ, Goldstein S, Stadtman ER. Age-related changes in oxidized proteins. J Biol Chem 262: 5488-5491, 1987.
125. Olzmann JA, Li L, Chin LS. Aggresome formation and neurodegenerative diseases: therapeutic implications. Curr Med Chem 15: 47-60, 2008.
126. Opazo C, Huang X, Cherny RA, Moir RD, Roher AE, White AR, Cappai R, Masters CL, Tanzi RE, Inestrosa NC, Bush AI. Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, biological reducing agents to neurotoxic H(2)O(2). J Biol Chem 277: 40302-40308, 2002.
127. Ostman A, Frijhoff J, Sandin A, Bohmer FD. Regulation of protein tyrosine phosphatases by reversible oxidation. J Biochem 150: 345-356, 2011.
128. Pacifici RE, Kono Y, Davies KJ. Hydrophobicity as the signal for selective degradation of hydroxyl radicalmodified hemoglobin by the multicatalytic proteinase complex, proteasome. J Biol Chem 268: 15405-15411, 1993.
129. Persson HL, Yu Z, Tirosh O, Eaton JW, Brunk UT. Prevention of oxidant-induced cell death by lysosomotropic iron chelators. Free Radic Biol Med 34: 1295-1305, 2003.
130. Petropoulos I, Conconi M, Wang X, Hoenel B, Bregegere F, Milner Y, Friguet B. Increase of oxidatively modified protein is associated with a decrease of proteasome activity and content in aging epidermal cells. J Gerontol A Biol Sci Med Sci 55: B220-B227, 2000.
131. Poppek D, Keck S, Ermak G, Jung T, Stolzing A, Ullrich O, Davies KJ, Grune T. Phosphorylation inhibits turnover of the tau protein by the proteasome: influence of RCAN1 and oxidative stress. Biochem J 400: 511-520, 2006.
132. Powell SR, Wang P, Divald A, Teichberg S, Haridas V, McCloskey TW, Davies KJ, Katzeff H. Aggregates of oxidized proteins (lipofuscin) induce apoptosis through proteasome inhibition and dysregulation of proapoptotic proteins. Free Radic Biol Med 38: 1093-1101, 2005.
133. Pratico D, Clark CM, Liun F, Rokach J, Lee VY, Trojanowski JQ. Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch Neurol 59: 972-976, 2002.
134. Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA 84: 2995-2998, 1987.
135. Radu RA, Mata NL, Nusinowitz S, Liu X, Sieving PA, Travis GH. Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration. Proc Natl Acad Sci USA 100: 4742-4747, 2003.
136. Rajavashisth TB,alibi A, Territo MC, Berliner JA, Navab M, Fogelman AM, Lusis AJ. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature 344: 254-257, 1990.
137. Reinheckel T, Sitte N, Ullrich O, Kuckelkorn U, Davies KJ, Grune T. Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem J 335 (Pt 3): 637-642, 1998.
138. Reinheckel T, Ullrich O, Sitte N, Grune T. Differential impairment of 20S and 26S proteasome activities in human hematopoietic K562 cells during oxidative stress. Arch Biochem Biophys 377: 65-68, 2000.
139. Shen JK, Dong A, Hackett SF, Bell WR, Green WR, Campochiaro PA. Oxidative damage in age-related macular degeneration. Histol Histopathol 22: 1301-1308, 2007.
140. Shringarpure R, Grune T, Mehlhase J, Davies KJ. Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome. J Biol Chem 278: 311-318, 2003.
141. Sitte N, Huber M, Grune T, Ladhoff A, Doecke WD, Von ZT, Davies KJ. Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts. FASEB J 14: 1490-1498, 2000.
142. Siu PM, Pistilli EE, Alway SE. Age-dependent increase in oxidative stress in gastrocnemius muscle with unloading. J Appl Physiol (1985) 105: 1695-1705, 2008.
143. Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, Markesbery WR. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci USA 88: 10540-10543, 1991.
144. Someya S, Tanokura M, Weindruch R, Prolla TA, Yamasoba T. Effects of caloric restriction on age-related hearing loss in rodents and rhesus monkeys. Curr Aging Sci 3: 20-25, 2010.
145. Squadrito GL and Pryor WA. Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, carbon dioxide. Free Radic Biol Med 25: 392-403, 1998.
146. Stadtman ER and Berlett BS. Reactive oxygen-mediated protein oxidation in aging and disease. Chem Res Toxicol 10: 485-494, 1997.
147. Stadtman ER and Levine RL. Free radical-mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids 25: 207-218, 2003.
148. Starke-Reed PE and Oliver CN. Protein oxidation and proteolysis during aging and oxidative stress. Arch Biochem Biophys 275: 559-567, 1989.
149. Stocker R and Keaney JF, Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 84: 1381-1478, 2004.
150. Terlecky SR, Chiang HL, Olson TS, Dice JF. Protein and peptide binding and stimulation of in vitro lysosomal proteolysis by the 73-kDa heat shock cognate protein. J Biol Chem 267: 9202-9209, 1992.
151. Terman A, Kurz T, Gustafsson B, Brunk UT. Lysosomal labilization. IUBMB Life 58: 531-539, 2006.
152. Todde V, Veenhuis M, van der Klei IJ. Autophagy: principles and significance in health and disease. Biochim Biophys Acta 1792: 3-13, 2009.
153. Toussaint O, Medrano EE, von Zglinicki T. Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes. Exp Gerontol 35: 927-945, 2000.
154. Vistoli G, De Maddis D, Cipak A, Zarkovic N, Carini M, Aldini G. Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radic Res 47 Suppl 1: 3-27, 2013.
155. Viteri G, Carrard G, Birlouez-Aragon I, Silva E, Friguet B. Age-dependent protein modifications and declining proteasome activity in the human lens. Arch Biochem Biophys 427: 197-203, 2004.
156. Vogiatzi G, Tousoulis D, Stefanadis C. The role of oxidative stress in atherosclerosis. Hellenic J Cardiol 50: 402-409, 2009.
157. Waxman EA and Giasson BI. Molecular mechanisms of alpha-synuclein neurodegeneration. Biochim Biophys Acta 1792: 616-624, 2009.
158. Weber D, Kneschke N, Grimm S, Bergheim I, Breusing N, Grune T. Rapid and sensitive determination of protein-nitrotyrosine by ELISA: Application to human plasma. Free Radic Res 46: 276-285, 2012.
159. Whittier JE, Xiong Y, Rechsteiner MC, Squier TC. Hsp90 enhances degradation of oxidized calmodulin by the 20 S proteasome. J Biol Chem 279: 46135-46142, 2004.
160. Wilkinson B and Gilbert HF. Protein disulfide isomerase. Biochim Biophys Acta 1699: 35-44, 2004.
161. Wolf G. Lipofuscin and macular degeneration. Nutr Rev 61: 342-346, 2003.
162. Zaarur N, Meriin AB, Bejarano E, Xu X, Gabai VL, Cuervo AM, Sherman MY. Proteasome failure promotes positioning of lysosomes around the aggresome via local block of microtubule-dependent transport. Mol Cell Biol 34: 1336-1348, 2014.
163. Zainal TA, Oberley TD, Allison DB, Szweda LI, Weindruch R. Caloric restriction of rhesus monkeys lowers oxidative damage in skeletal muscle. FASEB J 14: 1825-1836, 2000.
164. Zhao Y and Zhao B. Oxidative stress and the pathogenesis of Alzheimer's disease. Oxid Med Cell Longev 2013: 316523, 2013.